Justin Kirk-Bayley

Justin Kirk-Bayley

Auto-generated profile, based on publicly available information

Justin Kirk-Bayley

Royal Surrey NHS Foundation Trust, Guildford, UK

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2009 in British Journal of Anaesthesia
Verified
Journal Article
Open access
PDF file
MEM. E. Edsell
M. E. Edsell
JKJ. Kirk-Bayley
J. Kirk-Bayley
Editor—The June issue of the British Journal of Anaesthesia contained three informative articles discussing various aspects of gas embolism.1–3 In their report of paradoxical air embolus from a central venous catheter, Eichhorn and colleagues2 incorrectly state that ‘no specific treatment is available’ for the management of arterial gas embolism (AGE). Hyperbaric oxygen therapy (HBOT) has been an established treatment for both diving-related and iatrogenic AGE for many years. Although there are no randomized controlled trials demonstrating the positive effect of HBOT, there are numerous case reports and case series and also sound mechanistic principles that support its use in AGE.4,5 The high oxygen tension promotes the resorption of nitrogen from the bubble and the elevated ambient pressure reduces the size of the bubbles in accordance with Boyle's law. At 282 kPa (a conventional HBOT treatment pressure), spherical gas bubble diameter will be reduced to 82% with a resulting 45% decrease in volume, such that bubble passage through the microcirculation and resolution of embolic phenomena may occur. In their review of 27 case series, Moon and Gorman6 report substantial improvement in outcome in patients with AGE treated with HBOT. Three hundred and forty-six (78%) of the 441 who received HBOT fully recovered and 20 (4.5%) died. Of the 288 with no recompression therapy, 74 (26%) fully recovered and 151 (52%) died. We feel it is incumbent upon clinicians anaesthetizing patients at risk of AGE (such as those undergoing neurosurgery in the sitting position) to be aware of what, if any, services are available for the administration of HBOT should this complication occur. There are obvious limitations to HBOT, including the location of chambers (necessitating the transfer of critically ill patients) and the ability of those chambers to care for critically ill patients during the therapy. However, if facilities are available, HBOT should be considered immediately in cases of iatrogenic AGE as early treatment may improve outcome.4

19 May 2026 in Anaesthesia
Verified
Journal Article
Closed access
AMAshley Miller
Ashley Miller
JKJustin Kirk‐Bayley
Justin Kirk‐Bayley
MPMarcus Peck
Marcus Peck
JWJonathan Wilkinson
Jonathan Wilkinson

11 February 2023 in Journal of the Intensive Care Society
Verified
Journal Article
Closed access
MPMary Phillips
Mary Phillips
JZJessica Zekavica
Jessica Zekavica
RKRajesh Kumar
Rajesh Kumar
RLRajiv Lahiri
Rajiv Lahiri
JKJustin Kirk-Bayley
Justin Kirk-Bayley
AFAdam E Frampton
Adam E Frampton
The COVID-19 pandemic presented clinical and logistical challenges in the delivery of adequate nutrition in the critical care setting. The use of neuromuscular-blocking drugs, presence of maxilla-facial oedema, strict infection control procedures, and patients placed in a prone position complicated feeding tube placement. We audited the outcomes of dietitian-led naso-jejunal tube (NJT) insertions using the IRIS® (Kangaroo, USA) device, before and during the COVID-19 pandemic. NJT placement was successful in 78% of all cases ( n = 50), and 87% of COVID-19 cases. Anaesthetic support was only required in COVID-19 patients (53%). NJT placement using IRIS was more difficult but achievable in patients with COVID-19.


1 January 2004 in Critical Care
Verified
Journal Article
Open access
JKJustin Kirk-Bayley
Justin Kirk-Bayley
RVRichard Venn
Richard Venn

11 March 2026 in Journal of the Intensive Care Society
Verified
Journal Article
Closed access
MWManprit Waraich
Manprit Waraich
BZBogdana Zoica
Bogdana Zoica
EAEmma Alexander
Emma Alexander
JSJennie Stephens
Jennie Stephens
HCHannah Conway
Hannah Conway
JWJonathan Nicholas Wilkinson
Jonathan Nicholas Wilkinson
Neurological emergencies such as stroke and traumatic brain injury are major contributors to morbidity and mortality in critically ill patients. These conditions frequently result in alterations in cerebral haemodynamics, including raised intracranial pressure, which require timely recognition and management to optimise outcomes. Neuro point-of-care ultrasound (NeuroPOCUS), incorporating transcranial Doppler (TCD), transcranial colour-coded duplex (TCCD) ultrasound, and optic nerve sheath diameter (ONSD) measurement, offers a non-invasive, bedside means of assessing cerebral physiology and is increasingly recognised as a valuable adjunct in neurocritical care. Despite the successful adoption of point-of-care ultrasound in critical care through established accreditation pathways such as FUSIC ® and CACTUS ® , the UK has lacked a dedicated framework for NeuroPOCUS. To address this gap, we have developed and launched a UK-specific NeuroPOCUS accreditation programme, combining structured theoretical teaching with supervised practical training. The pathway addresses the distinct needs of both paediatric and adult populations, combining theoretical learning with practical application. Core learning materials include neuroanatomy, Doppler principles, standardised insonation techniques, and interpretation of cerebral blood flow velocities and indices such as pulsatility (PI) and resistivity (RI). Supporting resources feature videos of transcranial colour-coded Duplex (TCCD) imaging in normal subjects and clinical case examples. Participants will complete a logbook of 50 supervised cases, facilitated by remote mentorship. A novel accreditation pathway provides an opportunity for further research into the use of NeuroPOCUS in neurocritical care. This article outlines the core techniques of NeuroPOCUS, the physiological insights it offers, key clinical applications, and the proposed accreditation pathway aimed at standardising practice and clinician training in the care of critically ill patients with neurological injury or dysfunction.